Immunocytochemical localization of the dopamine transporter in human brain

Journal of Comparative Neurology

Volumn 409, Issue 1, 1999, Pages 38-56

  Ciliax, Brian J ^a,d   Drash, Genny W ^a   Staley, Julie K ^b   Haber, Sharon ^a   Mobley, Catherine J ^a   Miller, Gary W ^a   Mufson, Elliott J ^c   Mash, Deborah C ^b   Levey, Allan I ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

Antigen retrieval; Distribution; Double labeling; Immunocytochemistry; Tyrosine hydroxylase

Indexed keywords

DOPAMINE TRANSPORTER;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN REGION; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; MESENCEPHALON; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SUBSTANTIA NIGRA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN; BRAIN DISEASES; CARRIER PROTEINS; CORPUS STRIATUM; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONS; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; TISSUE DISTRIBUTION;

EID: 0033591616     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1     Document Type: Article

References (65)

1. Akil M, Lewis DA. 1994. The distribution of tyrosine hydroxylase-immunoreactive fibers in the human entorhinal cortex. Neuroscience 60:857-874.
2. Amara SG, Kuhar MJ. 1993. Neurotransmitter transporters: recent progress. Annu Rev Neurosci 16:73-93.
3. Amaral DG, Insausti R. 1990. Hippocampal formation. In: Paxinos G, editor. The human nervous system. New York: Academic Press. p 711-755.
4. Aubert I, Brana C, Pellevoisin C, Giros B, Caille I, Carles D, Vital C, Bloch B. 1997. Molecular anatomy of the development of the human substantia nigra. J Comp Neurol 379:72-87.
5. Baker RA, Herkenham M. 1995. Arcuate nucleus neurons that project to the hypothalamic paraventricular nucleus: neuropeptidergic identity and consequences of adrenalectomy on mRNA levels in the rat. J Comp Neurol 358:518-530.
6. Bannon MJ, Whitty CJ. 1997. Age-related and regional differences in dopamine transporter mRNA expression in human midbrain. Neurology 48:969-977.
7. Bannon MJ, Poosch MS, Xia Y, Goebel DJ, Cassin B, Kapatos G. 1992. Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age. Proc Natl Acad Sci USA 89:7095-7099.
8. Berger B, Gaspar P, Verney C. 1991. Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates. Trends Neurosci 14:21-27.
9. Bjorklund A, Lindvall O. 1984. Dopamine-containing systems in the CNS. In: Bjorklund, A, Hokfelt T, editors. Classical transmitters in the CNS, part I. Volume 2. New York: Elsevier, p 55-122.
10. Blanchard V, Raisman-Vozari R, Vyas S, Michel PP, Javoy-Agid F, Uhl G, Agid Y. 1994. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon. Brain Res Mol Brain Res 22:29-38.
11. Booze RM, Mactutus CF, Gutman CR, Davis JN. 1993. Frequency analysis of catecholamine axonal morphology in human brain. I. Effects of postmortem delay interval. J Neurol Sci 119:99-109.
12. Braak H. 1980. Architectonics of the human telencephalic cortex. Heidelberg: Springer-Verlag.
13. Burchett SA, Bannon MJ. 1997. Serotonin, dopamine and norepinephrine transporter mRNAs: heterogeneity of distribution and response to 'binge' cocaine administration. Brain Res Mol Brain Res 49:95-102.
14. Cerruti C, Walther DM, Kuhar MJ, Uhl GR. 1993. Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. Brain Res Mol Brain Res 18:181-186.
15. Chinaglia G, Alvarez FJ, Probst A, Palacios JM. 1992. Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol. Neuroscience 49:317-327.
16. Chronwall BM. 1985. Anatomy and physiology of the neuroendocrine arcuate nucleus. Peptides 6(Suppl 2):1-11.
17. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI. 1995. The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15:1714-1723.
18. Donnan GA, Kaczmarczyk SJ, Paxinos G, Chilco PJ, Kalnins RM, Woodhouse DG, Mendelsohn FA. 1991. Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography. J Comp Neurol 304:419-434.
19. Freed C, Revay R, Vaughan RA, Kriek E, Grant S, UhI GR, Kuhar MJ. 1995. Dopamine transporter immunoreactivity in rat brain. J Comp Neurol 359:340-349.
20. Gaspar P, Berger B, Febvret A, Vigny A, Henry JP. 1989. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-beta-hydroxylase. J Comp Neurol 279:249-271.
21. George SR, Van Loon GR. 1982. Characterization of high affinity dopamine uptake into the dopamine neurons of the hypothalamus. Brain Res 234:339-355.
22. Giros B, Caron MG. 1993. Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43-49.
23. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
24. Goldman-Rakic PS, Lidow MS, Smiley JF, Williams MS. 1992. The anatomy of dopamine in monkey and human prefrontal cortex. J Neural Transmiss 36(Suppl):163-177.
25. Haber SN, Ryoo H, Cox C, Lu W. 1995. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity. J Comp Neurol 362:400-410.
26. Hersch S, Ciliax B, Gutekunst C-A, Rees H, Heilman C, Yung K, Bolam J, Ince E, Yi H, Levey A. 1995. Electron microscopic analysis of D1 and D2 dopamine receptor proteins in the dorsal striatum and their synaptic relationships with motor corticostriatal afferents. J Neurosci 15:5222-5237.
27. Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI. 1997. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388:211-227.
28. Iijima K, Ogawa T. 1981. An HRP study on the distribution of all nuclei innervating the supraoptic nucleus in the rat brain. Acta Histochem 69:274-295.
29. Kantor L, Gnegy ME. 1998. Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J Pharmacol Exp Ther 284:592-598.
30. Kitayama S, Shimada S, Uhl GR. 1992. Parkinsonism-inducing neurotoxin MPP+: uptake and toxicity in nonneuronal COS cells expressing dopamine transporter cDNA. Ann Neurol 32:109-111.
31. Kopin IJ, Markey SP. 1988. MPTP toxicity: implications for research in Parkinson's disease. Annu Rev Neurosci 11:81-96.
32. Kuhar MJ, Vaughan R, Uhl G, Cerruti C, Revay R, Freed C, Nirenburg M, Pickel V. 1998. Localization of dopamine transporter protein by microscopic histochemistry. Adv Pharmacol 42:168-170.
33. Levey AI, Bolam JP, Rye DB, Hallanger AE, Demuth RM, Mesulam MM, Wainer BH. 1986. A light and electron microscopic procedure for sequential double antigen localization using diaminobenzidine and benzidine dihydrochloride. J Histochem Cytochem 34:1449-1457.
34. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR, Ciliax BJ. 1993. Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90:8861-8865.
35. Lewis DA, Sesack SR, Levey AI, Rosenberg DR. 1998. Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development. Adv Pharmacol 42:703-706.
36. Ma SY, Ciliax BJ, Jaffar S, Stebbins G, Joyce J, Kordower JH, Levey AI, Mash DC, Mufson EJ. 1999. Dopamine transporter immunoreactive neurons decrease with age in the human substantia nigra: a stereologic analysis. J Comp Neurol. 409:25-37.
37. Malison RT, McDougle CJ, van Dyck CH, Scahill L, Baldwin RM, Seibyl JP, Price LH, Leckman JF, Innis RB. 1995. [123I]Beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry 152:1359-1361.
38. Meister B, Elde R. 1993. Dopamine transporter mRNA in neurons of the rat hypothalamus. Neuroendocrinology 58:388-395.
39. Mennicken F, Savasta M, Peretti RR, Feuerstein C. 1992. Autoradiographic localization of dopamine uptake sites in the rat brain with 3H-GBR 12935. J Neural Transmiss Genet Sect 87:1-14.
40. Miller GW, Staley JK, Heilman CJ, Perez JT, Mash DC, Rye DB, Levey AI. 1997. Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann Neurol 41:530-539.
41. Miller GW, Gilmor ML, Levey AI. 1998. Generation of transporter specific antibodies. Methods Enzymol 296:407-422.
42. Mufson EJ, Jaffar S, Ciliax BJ, Joyce JN, Mash DC, Levey AI. 1997. Dopamine transporter (DAT) immunoreactivity within the human substantia nigra decreases with age. Soc Neurosci Abstr 23:1456.
43. Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. 1996. The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16:436-447.
44. Nirenberg MJ, Chan J, Pohorille A, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. 1997a. The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J Neurosci 17:6899-6907.
45. Nirenberg MJ, Chan J, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. 1997b. Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area. J Neurosci 17:5255-5262.
46. Niznik HB, Fogel EF, Fassos FF, Seeman P. 1991. The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus. J Neurochem 56:192-198.
47. Nobin A, Bjorklund A. 1973. Topography of the monoamine neuron systems in the human brain as revealed in fetuses. Acta Physiol Scand 388(Suppl):1-40.
48. Olson L, Boreus LO, Seiger A. 1973. Histochemical demonstration and mapping of 5-hydroxytryptamine-and catecholamine-containing neuron systems in the human fetal brain. Zeitschr Anat Entwicklungs 139:259-282.
49. Pearson J, Goldstein M, Markey K, Brandeis L. 1983. Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. Neuroscience 8:3-32.
50. Pearson J, Halliday G, Sakamoto N, Michel J-P. 1990. Catecholaminergic Neurons. In: Paxinos G, editor. The human nervous system. New York: Academic Press, p 1023-1049.
51. Pifl C, Giros B, Caron MG. 1993. Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J Neurosci 13:4246-4253.
52. 3H]GBR 12,935 binding. Mol Pharmacol 45:125-135.
53. Puelles L, Medina L. 1994. Development of neurons expressing tyrosine hydroxylase and dopamine in the chicken brain: a comparative segmental analysis. In: Smeets WJAJ, Reiner A, editors. Phylogeny and development of catecholamine systems in the CNS of vertebrates. New York: Cambridge University Press, p 381-404.
54. Revay R, Vaughan R, Grant S, Kuhar MJ. 1996. Dopamine transporter immunohistochemistry in median eminence, amygdala, and other areas of the rat brain. Synapse 22:93-99.
55. Sesack SR, Hawrylak VA, Guido MA, Levey AI. 1998a. Cellular and subcellular localization of the dopamine transporter in rat cortex. Adv Pharmac 42:171-174.
56. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI. 1998b. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18:2697-2708.
57. Shi SR, Cote RJ, Young L, Imam SA, Taylor CR. 1996. Use of pH 9.5 Tris-HCl buffer containing 5% urea for antigen retrieval immunohistochemistry. Biotech Histochem 71:190-196.
58. Simon H, Le Moal M, Calas A. 1979. Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase. Brain Res 178:17-40.
59. Singer HS, Hahn IH, Moran TH. 1991. Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol 30:558-562.
60. Smeets WJAJ, Reiner A. 1994. Catecholamines in the CNS of vertebrates: current concepts of evolution and functional significance. In: Smeets WJAJ, Reiner A, editors. Phylogeny and development of catecholamine systems in the CNS of vertebrates. New York: Cambridge University Press. p 463-481.
61. Smiley JF, Williams SM, Szigeti K, Goldman-Rakic PS. 1992. Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex. J Comp Neurol 321:325-335.
62. Staley JK, Basile M, Flynn DD, Mash DC. 1994. Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization. J Neurochem 62:549-556.
63. Staley JK, Boja JW, Carroll FI, Seltzman HH, Wyrick CD, Lewin AH, Abraham P, Mash DC. 1995. Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121. Synapse 21:364-372.
64. Uhl GR, Walther D, Mash D, Faucheux B, Javoy-Agid F. 1994. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons. Ann Neurol 35:494-498.
65. Zigmond MJ, Abercrombie ED, Berger TW, Grace AA, Stricker EM. 1990. Compensations after lesions of central dopaminergic neurons: some clinical and basic implications. Trends Neurosci 13:290-296.